Abstract:WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Genetic polymorphisms of VKORC1 and CYP2C9 are known to influence warfarin dosage. * Recent studies among Caucasians showed that polymorphisms of CYP4F2 also play a role in warfarin pharmacogenetics. * The contribution of CYP4F2 variants to the variability inwarfarin dose requirement in Chinese subjects remains to be investigated. WHAT THIS STUDY ADDS * This research was to study the effect of CYP4F2 variants on warfarin requirements in the Han Chinese population. * This study developed a multiple regression model including CYP2C9, VKORC1 3673G>A, CYP4F2 genotypes and age, weight, combination use of amiodarone which could explain 56.1% of the individual variability in warfarin dose CYP4F2 could explain 4% of the variance in warfarin dose. * We found that one novel genotypic polymorphism 5417G>T for Asp36Tyr, which was identified as an important marker of warfarin resistance, was absent in the Han Chinese population in our study. AIMS The objective of this study was to assess the effect of the CYP4F2 on the daily stable warfarin dose requirement in Han Chinese patients with mechanical heart valve replacement (MHVR). METHODS From March 2007 to November 2008, 222 Han Chinese MHVR patients were recruited in our study. VKORC1 3673G>A, 5417G>T, CYP2C9*3 and CYP4F2 rs2108622 were genotyped by using the polymerase chain reaction restriction fragment length polymorphism method (PCR-RFLP). Polymorphisms of VKORC1 9041G>A were detected by direct sequencing. Multiple linear regression analysis was used to investigate the contribution of CYP4F2. RESULTS The CYP4F2 rs2108622 CT/TT group took a significantly higher stable warfarin dose (3.2 mg day(-1)) than the CC group (2.9 mg day(-1), 95% CI 0.2, 1.0, P= 0.033). The multiple linear regression model included VKORC1 3673G>A, CYP2C9, CYP4F2 genotypes and clinical characteristics. The model could explain 56.1% of the variance in stable warfarin dose in Han Chinese patients with MHVR. CYP4F2 contributed about 4% to the variance in the warfarin dose. There was no variation in the SNPs of VKORC1 5417G>T. CONCLUSION CYP4F2 is a minor significant factor of individual variability in the stable warfarin dose in Han Chinese patients with MHVR. The effect of CYP2C9 and VKORC1 genotypes on variability in the stable warfarin dose had also been confirmed.

The Association Between GGCX, Mir-133 Genetic Polymorphisms and Warfarin Stable Dosage in Han Chinese Patients with Mechanical Heart Valve Replacement.

CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.

Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients

Impact of Gene Polymorphism on the Initiation and Maintenance Phases of Warfarin Therapy in Chinese Patients Undergoing Heart Valve Replacement

Warfarin Dosage Response Related Pharmacogenetics In Chinese Population

CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement: CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose

Polymorphisms in the Genes for Coagulation Factor II, V, VII in Patients Undergoing Coronary Angiography

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement

Effects of CYP2C9 and VKORC1 Genetic Polymorphisms in Chinese Han Population on Maintenance Dosage of Warfarin

Study of the Association Between VKORC1-1173C>T Polymorphism and Warfarin Maintenance Dose

Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX Polymorphisms on Warfarin Maintenance Dose: Exploring a New Algorithm in South Chinese Patients Accept Mechanical Heart Valve Replacement

Genetic factors contribute to patient-specific warfarin dose for Han Chinese.

Genotype-guided Warfarin Dosing in Patients with Mechanical Valves: a Randomized Controlled Trial.

Influence of Ggcx Genotype on Warfarin Dose Requirements in Chinese Patients

Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.

Impact of NR1I2 polymorphisms on warfarin maintenance dose and its inter-individual variation

Clinical Application Of Pharmacogenetic-Based Warfarin-Dosing Algorithm In Patients Of Han Nationality After Rheumatic Valve Replacement: A Randomized And Controlled Trial

Effect of Multiple Single-Nucleotide Variants in VKORC1 Gene on the Maintenance Doses of Warfarin

Correlation Between Single Nucleotide Polymorphisms in CYP4F2 and Warfarin Dosing in Chinese Valve Replacement Patients.

Identification of Two Novel Genes SLC15A2 and SLCO1B3 Associated with Maintenance Dose Variability of Warfarin in a Chinese Population